AI Regulating in Healthcare: Values, Ethics, and Governance With: Dr. Colleen Lyons
Dr. Colleen Lyons, Trust and Change Ambassador at the FDA, discusses the need for thoughtful regulation of AI in healthcare. She warns that overly deregulated markets create hype cycles that end in collapse, while overregulation can stifle innovation and entrench incumbents. Drawing parallels to the dotcom boom and bust, she highlights the dangers of unchecked growth followed by heavy-handed compliance regimes like Sarbanes-Oxley. Lyons stresses that regulation alone is insufficient—organizations must embed ethics and values into their culture to complement legal frameworks. She introduces her concept of 'sturdy leadership,' emphasizing the importance of democratizing values, encouraging employees to speak up, and treating AI as both a technology and a change management challenge. Ultimately, she argues that sustainable AI governance requires balancing innovation with ethical responsibility.
Episode Contents:
About the Guest
Dr. Colleen Lyons is an ethics and AI governance expert serving as Trust and Change Ambassador at the FDA. She focuses on liability, organizational change, and embedding values to ensure responsible AI adoption in healthcare.
Key Takeaways
- Overregulation stifles innovation, while deregulation fuels risky hype cycles
- Ethics and values must complement legal compliance for AI sustainability
- AI adoption is as much a change management challenge as a technical one
Transcript Summary
What are the pros and cons of regulating AI in healthcare?
Overregulation entrenches incumbents, while deregulation fuels hype and collapse.
What role should values play?
Ethics and values must be embedded into organizational culture, beyond compliance checklists.
How should we view AI adoption?
AI is both a technology and a change management initiative requiring sturdy leadership.
More Topics
- AI in Patient Care
- AI in the Healthcare Industry
- AI and Medical Innovation
- Healthcare Ethics and Policy
Keep Exploring
About the Series
AI and Healthcare—with Mika Newton and Dr. Sanjay Juneja is an engaging interview series featuring world-renowned leaders shaping the intersection of artificial intelligence and medicine.
Dr. Sanjay Juneja, a hematologist and medical oncologist widely recognized as “TheOncDoc,” is a trailblazer in healthcare innovation and a rising authority on the transformative role of AI in medicine.
Mika Newton is an expert in healthcare data management, with a focus on data completeness and universality. Mika is on the editorial board of AI in Precision Oncology and is no stranger to bringing transformative technologies to market and fostering innovation.